Genetics and Genomics Pharmacogenomics

Overview

Pharmacogenomics is the study of how a person's genetic makeup influences their response to medicines, combining the fields of genetics, genomics, and pharmacology. Individuals can differ in genes that affect how drugs are metabolized, transported, or act on their targets, and these differences help explain why the same medication may be highly effective for one person, ineffective for another, or cause adverse effects in someone else. By identifying genetic variants linked to drug response, pharmacogenomics supports personalized or precision medicine, in which treatment choices and doses can be tailored to a patient's genetic profile to improve effectiveness and reduce harm. The broader fields of genetics and genomics provide the foundation for this work, mapping the genes and genomic variation that underlie human biology and disease. Within the journal's coverage of Advanced Pharmaceutical Science And Technology, pharmacogenomics connects genomic science to drug discovery, dosing, and safety. This page gathers peer-reviewed, open-access research relevant to genetics, genomics, and pharmacogenomics, offering a reference point for readers interested in how genetic variation shapes drug response and how genomic information is applied to develop and individualize therapies.

Research published in this journal

1 peer-reviewed article, ranked by relevance. Each links to its DOI.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics